Use of ibritumomab tiuxetan anti-CD20 radioimmunotherapy in a non-Hodgkin's lymphoma patient previously treated with a yttrium-90-labeled anti-CD22 monoclonal antibody.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples